Effects of long-term infection with bovine immunodeficiency virus and/or bovine leukemia virus on antibody and lymphocyte proliferative responses in cattle

Natural Infection of Dairy Cows with Bovine Leukemia Virus Affects Immunoglobulin Levels in Saliva and Serum but Not Milk

Bovine leukemia virus (BLV) is a retroviral infection that disrupts the immune function of infected animals. It is widespread among U.S. dairy cattle. In this pilot study, the average total IgA and IgM concentrations in milk, saliva, and serum samples from BLV ELISA-positive (ELISA+) dairy cows were compared against samples from BLV ELISA-negative (ELISA−) cows using the Kruskal–Wallis test (with ties). The results from ELISA+ cows were also stratified by lymphocyte count (LC) and proviral load (PVL). In milk and saliva from ELISA+ cows, the average total IgA and IgM concentrations were decreased compared to ELISA− cows, although this was only statistically significant for saliva IgM in cows with low PVL (p = 0.0424). Numerically, the average total IgA concentrations were 33.6% lower in milk and 23.7% lower in saliva, and the average total IgM concentrations were 42.4% lower in milk and 15.5% lower in saliva. No significant differences were observed in the total serum IgA concentrations, regardless of PVL and LC. The total serum IgM from ELISA+ cows was significantly decreased (p = 0.0223), with the largest decreases occurring in the highest PVL and LC subgroups. This pilot study is a first step in investigating the impact of BLV on mucosal immunity and will require further exploration in each of the various stages of disease progression.

Differential effect of IFN-tau on proliferation and distribution of lymphocyte subsets in one-way mixed lymphocyte reaction in cows and heifers

IFN-tau is a signaling protein secreted by the bovine conceptus during the peri-implantation period and responsible for pregnancy recognition. Its main role is the prevention of pulsatile release of luteolytic PGF2alpha, but it also exerts immunomodulatory activities characteristic for other type I interferons. The aim of the study was to examine the effect of IFN-tau on the proliferation and distribution of peripheral blood lymphocyte subsets during one-way mixed lymphocyte reaction (MLR) in cows and heifers. IFN-tau inhibited the proliferative response of lymphocytes in MLR both in cows and heifers in a dose-dependent manner, but cow lymphocytes were less susceptible than those ones from heifers. It was also showed that IFN-tau differentially changed lymphocyte subsets distribution in MLR in cows and heifers. In cows, the relative percentage of CD8(+) cells after MRL in the presence of IFN-tau was significantly lower than in heifers. Differential effect of rIFN-tau on proliferation and lymphocyte subsets distribution in a one-way MRL in cows and heifers indicated that the age of the mother is an important factor in immunomodulatory effect towards developing bovine embryo.

Failure to detect bovine immunodeficiency virus contamination of stud bull spermatozoa, blood leukocytes, or semen leukocytes in samples supplied by artificial insemination centers

OBJECTIVE

To determine whether bovine immunodeficiency virus (BIV) infection could be detected in spermatozoa, blood leukocytes, or semen leukocytes from stud bulls in artificial insemination centers.

ANIMALS

30 bulls at 3 artificial insemination centers.

PROCEDURE

Polymerase chain reaction testing that used 3 sets of primer pairs targeting pol and env regions of the BIV proviral genome was performed on DNA extracted from semen leukocytes, spermatozoa, and blood leukocytes from each bull. Southern blot analysis was performed to increase sensitivity of detection. Western blot analysis of plasma samples was used to detect antibodies against BIV.

RESULTS

BIV provirus was not detected in DNA samples obtained from semen leukocytes, spermatozoa, or blood leukocytes, and antibodies against BIV were not detected.

CONCLUSIONS AND CLINICAL RELEVANCE

Contrary to our report of high point prevalence of BIV contamination of semen from a single artificial insemination center, bulls of the study reported here did not appear to be infected. Maximum risk of BIV infection in similar bulls was estimated at 10% with a confidence level of 95%.

Increased MHC class II and CD25 expression on lymphocytes in the absence of persistent lymphocytosis in cattle experimentally infected with bovine leukemia virus

We recently observed that a group of cattle experimentally infected with bovine leukemia virus (BLV) had enhanced antibody responses to recall antigens. None of the cattle in this group were classified as persistently lymphocytotic, but they did have significantly increased numbers of circulating T and B cells. In order to investigate the potential mechanisms of BLV-induced immune activation, dual-color flow cytometry was used to compare the expression of MHC class II (MHC II) molecules and the inducible IL-2 receptor alpha chain, CD25, on lymphocyte subsets in freshly isolated and cultured PBMC from these same BLV-infected cattle (n=5) with that of age-matched, uninfected controls (n=3). Freshly isolated peripheral blood mononuclear cells (PBMC) from BLV-infected cattle were found to contain a significantly higher percentage of B cells that expressed MHC II molecules (p<0.01). In addition, an increased proportion of CD4+ T cells from BLV-infected cattle expressed MHC II molecules after 20 h of Concanavalin A (Con A) stimulation (p<0.05), and MHC II expression was increased on both CD4+ (p<0.01) and CD8+ (p<0.05) T cells from BLV-infected cattle after 68 h in vitro, even in the absence of exogenous mitogen. Although CD25 expression was not increased on freshly isolated lymphocytes from BLV-infected cattle, an increased percentage of B cells from BLV-infected cattle expressed CD25 after 20 h of culture, either in the presence (p<0.05) or absence (p<0.01) of Con A. Thus, in addition to causing alterations in absolute numbers of circulating lymphocytes, BLV infection appears to cause a functional activation of both B and T cells, even in cattle that are non-lymphocytotic. It is likely that these BLV-induced alterations in lymphocyte activation status contributed to the previously observed enhancement of antibody responses in vivo.